Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Royce Biomedical (RYBO-BB) - any thoughts? -- Ignore unavailable to you. Want to Upgrade?

To: Neil_98 who wrote (29)	7/14/1998 8:14:00 PM
From: Neurogenesis	Respond to of 42

Don't worry Neil, no one is following this thread anyway. By the way, how's the lab in Irvine doing? Also, 'by the way', why on earth would you send a "private message" and then duplicate it as a public message? That seems to defeat the purpose of the former. I look forward to hearing all about Royce Biomedical in the future. Is it possible that Royce will be the shell for "Knight and Day"?

To: Neil_98 who wrote (29)	7/15/1998 1:38:00 PM
From: Neil_98	Respond to of 42

Here is a copy of our latest news release, feel free to call with any questions. ---------------------------- Royce Biomedical New Release OTC-BB Symbol RYBO July 14, 1998 Suite 905 - 475 Howe Street Vancouver, BC Canada, V6C 2B3 Toll Free: 1-800-661-7844 1-604-689-1924 Fax: 604-6898903 www.roycebiomedical.com ir@roycebiomedical.com Resignation of President The Board of Directors of Royce Biomedical Inc. are pleased to announce that Mr. Ken Pappas has been named Chairman of the Board for the Company. Mr. Pappas has tendered his resignation as Company President effective July 14, 1998. An announcement regarding the appointment of the Company's new President will be made tomorrow. Royce Biomedical Inc., (RYBO-OTC Bulletin Board) is a state of the art developer, manufacturer and marketer of rapid result, medical diagnostic test kits with offices in Beijing, China and corporate Head Offices in Vancouver, British Columbia, Canada. Royce is maintaining its objectives for rapid and consistent growth through the implementation of a progressive sales and marketing program. "Signed" Ken Pappas President

To: Neil_98 who wrote (29)	7/15/1998 1:41:00 PM
From: Neil_98	Read Replies (1) \| Respond to of 42

Here is our next release. Things are looking better. ----------------------------- NEWS RELEASE Date: July 15, 1998 Trading Symbol OTC BB : RYBO New President Appointed Mr. Ken Pappas, Chairman of the Board for Royce Biomedical Inc., is pleased to announce that Mr. Gregory Sharpe has accepted the position as President of the company. Mr. Sharpe will officially assume his duties and responsibilities on July 15, 1998. Mr. Sharpe brings to Royce Biomedical substantial knowledge of business systems and government process in many foreign countries. He has spent over 10 years in the international marketplace with experience in the creation of representative offices and joint ventures abroad. He brings strong communication skills, product development knowledge, and international marketing experience to the company. Prior to accepting this appointment, Mr. Sharpe spent two months conducting his due diligence on the company. He states, "I am very impressed with the simplicity and accuracy of Royce's technology. An analysis of the potential market for Royce's product line was also extremely positive. I am convinced that with dedicated management and leadership these products will sell." Royce Biomedical Inc., (RYBO-OTC Bulletin Board) is a state of the art developer, manufacturer and marketer of rapid result, medical diagnostic test kits with offices in Beijing, China and corporate Head Offices in Vancouver, British Columbia, Canada. Royce is maintaining its objectives for rapid and consistent growth through the implementation of a progressive sales and marketing program. "signed" Ken Pappas Chairman of the Board